Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €10.90 EUR
Change Today -0.85 / -7.23%
Volume 0.0
RAH On Other Exchanges
As of 10:23 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by RECRO PHARMA INC (RAH) in the last 6 months

Announced 07/1/15
16.00M for Recro Pharma, Inc.
Private Placement

Recro Pharma, Inc. (NasdaqCM:REPH) announced that it has entered into a definitive purchase agreement for private placement of 1,379,311 shares at $11.60 per share for gross proceeds of $16,000,008 on July 1, 2015. The transaction will involve participation three investors including institutional investors. The transaction is expected to close on or about July 7, 2015 and is subject to the satisfaction of customary closing condition. The securities will be issued pursuant ...
Read More

RAH's price was unchanged after the transaction was announced on 07/1/15.
Announced 03/9/15
170.00M for Elan Holdings, Inc. and Daravita Limited

Recro Pharma, Inc. (NasdaqCM:REPH) agreed to acquire Alkermes Gainesville LLC and Daravita Limited from Alkermes Pharma Ireland Limited and Eagle Holdings USA, Inc. for approximately $170 million on March 7, 2015. Recro Pharma will acquire Alkermes Gainesville LLC from Eagle Holdings USA, Inc. and Daravita Limited from Alkermes Pharma Ireland Limited. The consideration will be satisfied by $50 million in cash and receipt by Alkermes Pharma Ireland of up to $120 million ...
Read More

RAH's price was unchanged after the transaction was announced on 03/9/15.
Investor / Buyer
Recro Pharma, Inc.
Creditor / Lender
Alkermes Pharma Ireland Limited
Eagle Holdings USA, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RAH:GR €10.90 EUR -0.85

RAH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RAH.
View Industry Companies

Industry Analysis


Industry Average

Valuation RAH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.9x
Price/Book 7.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RECRO PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at